AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 61 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | 0.0% | 1,930 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -66.7% | 1,930 | +411.9% | 0.00% | – |
| Q3 2020 | $3,000 | 0.0% | 377 | +3.9% | 0.00% | – |
| Q2 2020 | $3,000 | -25.0% | 363 | -28.8% | 0.00% | – |
| Q4 2018 | $4,000 | -66.7% | 510 | -60.9% | 0.00% | – |
| Q3 2018 | $12,000 | -25.0% | 1,304 | -14.4% | 0.00% | – |
| Q2 2018 | $16,000 | +100.0% | 1,523 | +96.0% | 0.00% | – |
| Q1 2018 | $8,000 | +700.0% | 777 | +203.5% | 0.00% | – |
| Q2 2017 | $1,000 | – | 256 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $891,000 | 15.31% |
| Aisling Capital Management LP | 1,691,151 | $13,445,000 | 2.68% |
| GREAT POINT PARTNERS LLC | 900,000 | $7,155,000 | 1.67% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $22,639,000 | 1.40% |
| Altium Capital Management LP | 609,689 | $4,847,000 | 1.27% |
| Sio Capital Management, LLC | 446,000 | $3,546,000 | 1.13% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,953,000 | 1.12% |
| Samsara BioCapital, LLC | 883,720 | $7,026,000 | 1.10% |
| Lion Point Capital, LP | 300,000 | $2,385,000 | 0.45% |
| Abingworth LLP | 240,500 | $1,912,000 | 0.43% |